A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients

NCT07408219 · clinicaltrials.gov ↗
RECRUITING
Status
350
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Novartis Pharmaceuticals